Metastatic Hormone Refractory Prostate Cancer Withdrawn Phase 4 Trials for Goserelin (DB00014)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Withdrawn4 IdentifierTitlePurposeDrugs
NCT00255268CMAB vs IMAB in Metastatic Prostate CancerTreatment